Stem cell and exosome joint injections place biological material directly into a worn joint to support the body’s own repair. At RegenHaus Medical in Alpharetta, every joint procedure is physician-led and placed under live ultrasound guidance, so the material reaches the joint space it was meant for.
Physician-led · Same-week appointments · No obligation
If you have had a cortisone shot in a knee or shoulder, you know the pattern. The pain quiets for a few months, then returns, and the next injection does less. Underneath it, cartilage keeps thinning, mornings stay stiff, and the joint gives you less range than it used to.
Quiet the inflammation and leave the cartilage as it was. Relief tends to shorten with each repeat injection.
Sit between repeated steroid shots and surgery: biological material placed into the joint space to support repair.
The right answer for end-stage joints. Not the only answer before that point.
It is not right for everyone, which is the first thing we establish at your consultation.
These injections deliver biological material into one specific joint to support the local repair environment. The two materials are not the same thing, and that difference matters.
A joint injection is targeted. The material is placed into one joint space rather than circulated through the body, which is what makes accurate placement matter. Your physician explains what applies to your case.
We pinpoint the source of degeneration with localized imaging before treating anything.
Individualized to the joint and to your goals, with realistic expectations set.
Precise delivery into the joint space, performed in office.
Guided aftercare, then monitoring of your response over the following months.
Every joint procedure at RegenHaus is performed under live, real-time ultrasound guidance. That is not standard across the industry.
Injections placed by feel rely on surface landmarks, and accuracy studies across multiple joints show that unguided injections miss the intended space in a meaningful share of cases. If the material does not reach the joint, it cannot do what it was meant to do. The same guidance applies across our orthobiologics program.
Knee osteoarthritis and cartilage wear
Shoulder and rotator cuff degeneration
Hip joint degeneration and stiffness
Chronic tendinopathy and soft tissue injuries
Sports strains and overuse injuries in other joints
A consultation is how you find out. We review your imaging, identify which joint is driving your pain, and tell you plainly whether this is a reasonable option for you.
The same physician evaluates you, treats you, and manages follow-up.
Not on request, not on select cases.
We separate what research supports from what is preliminary, before you decide.
Where clinically appropriate, care can be delivered at your home or office.
Connected to our orthobiologics, exosome therapy, and peptide programs. Meet the physicians.
Research is active and stronger for some joints than others, with knee osteoarthritis the most studied. We tell you what applies to your diagnosis. See our research.
Improvement usually develops gradually over several weeks to a few months. Some patients do not respond, and we track for that.
Many regenerative products, including exosome products, are not FDA-approved, and the FDA has warned about unapproved exosome products. We tell you the status of what is recommended for you.
Screening comes first. Your physician reviews your history, medications, prior injections, and imaging before any procedure. Two concerns come up often, rejection and tumor risk, and both deserve a direct answer. Sourcing and screening address the first, and long-term data on the second is still limited, which we say plainly. Procedural risks include infection, bleeding, nerve or vessel irritation, and temporary soreness.
You are generally not a candidate if you have
Joint injection treatment may not be covered by insurance, and coverage varies by plan, so contact us for individualized treatment and payment information.
RegenHaus Medical is on the North Point Parkway corridor in Alpharetta, just off GA 400. Patients travel to us from across North Fulton and Forsyth County, including Johns Creek, Milton, Roswell, Cumming, Suwanee, Sandy Springs, and Buckhead. See all areas we serve.
Knee osteoarthritis is the most studied application, and research is active rather than settled. Results vary by patient and stage, and earlier stages tend to respond better.
Many regenerative products, including exosome products, are not FDA-approved, and the FDA has issued warnings about unapproved exosome products. We tell every patient the status of what is being recommended to them.
Stem cells are cells that can develop into other cell types. Exosomes are messengers released by cells, not cells themselves. PRP is prepared from a patient’s own blood. Different materials, different preparation, different evidence.
Rejection is addressed through sourcing and screening before any procedure. Tumor risk is the concern behind most hesitation about cell-based treatment, and long-term data remains limited, which we say plainly rather than talk around.
No. A joint injection places material into one specific joint space under ultrasound guidance. That is a targeted procedure, not a systemic one, and there is no IV step in our process.
It may not be, and coverage varies by plan and procedure. Contact us for individualized treatment and payment information.
If steroid injections have stopped working and you are not ready for surgery, the next step is an evaluation. We review your imaging, identify which joint is driving your pain, and tell you plainly whether this is a reasonable option for you.
I had been struggling with chronic knee pain for years, and nothing seemed to help—until I found RegenHaus Medical. Their non-invasive approach made a world of difference. I’m now walking pain-free and even back to enjoying my morning jogs. I can’t thank them enough!
Sarah T. Alpharetta, GA